Plant-based omega-3: How perilla oil affected blood and inflammation in smokers.

Perilla oil clinical trial finds cardiovascular benefits in healthy smokers

The new perilla oil clinical trial found that eight weeks of supplementation improved platelet function, increased circulating omega-3 fatty acids and reduced inflammatory gene expression in healthy smokers.

Conducted by researchers at Seoul National University of Science and Technology, the randomised, double-blind, placebo-controlled trial provides human clinical evidence for cardiovascular effects previously associated mainly with laboratory and animal research.

Participants receiving 4.8 grams of perilla oil daily showed a significant prolongation in collagen-induced ADP closure time, indicating altered platelet activity, alongside reductions in expression of the inflammatory genes TNF-α and TBX21.

Blood analysis also demonstrated higher concentrations of alpha-linolenic acid (ALA) and an increase in circulating eicosapentaenoic acid (EPA). The findings are particularly relevant because smoking promotes oxidative stress, inflammation, endothelial dysfunction and thrombosis, all of which contribute to cardiovascular disease. The study does not establish that perilla oil prevents heart attacks or strokes, but it identifies measurable biological effects that warrant larger and longer clinical trials.

Key Takeaways

Eight weeks of perilla oil supplementation altered platelet function in healthy smokers.
Perilla oil substantially increased circulating ALA and modestly increased EPA.
Inflammatory TNF-α and TBX21 gene expression declined after supplementation.
The study examined biological cardiovascular markers, not heart attacks or strokes.
Smoking cessation remains substantially more important than any dietary supplement.

A traditional Korean oil enters modern cardiovascular research

Perilla oil has been part of East Asian food culture for centuries, particularly in Korea, where oil extracted from the seeds of Perilla frutescens is used in cooking and seasoning. The plant’s leaves are also widely consumed, including fresh, pickled and wrapped around prepared foods.

What has traditionally been regarded as a culinary ingredient is now attracting attention from nutritional scientists because its seed oil contains unusually high concentrations of alpha-linolenic acid, or ALA, a plant-derived omega-3 polyunsaturated fatty acid.

The new clinical evidence comes from a research team led by Professor Ji Yeon Kim of the Department of Food Science and Biotechnology at Seoul National University of Science and Technology, working with researchers associated with CHA University.

Their study, published in Food & Function, examined whether regular perilla oil consumption could influence platelet responses and inflammatory processes in people exposed to a particularly important cardiovascular stressor: cigarette smoking.

The paper, titled “Effects of perilla oil on platelet and inflammatory responses in healthy smokers: a randomized, double-blind, placebo-controlled, parallel trial”, was first published online on May 13, 2026 and subsequently appeared in volume 17 of Food & Function on June 22, 2026.

Its importance lies less in the idea that an oil can somehow counteract smoking and more in the quality of the evidence. Randomised, double-blind, placebo-controlled human trials occupy an important position in clinical nutrition research because they can distinguish biological effects associated with an intervention from changes caused by expectation, behaviour or other variables.

Why researchers studied smokers

Smoking provides an unusually informative environment for investigating vascular biology. Tobacco smoke exposes the body to oxidants and numerous other compounds that can promote oxidative stress, inflammation, endothelial dysfunction and abnormal platelet activation. These processes contribute to atherosclerosis and thrombosis, which are central mechanisms behind many heart attacks and ischemic strokes.

The SeoulTech researchers therefore selected healthy smokers rather than people with established cardiovascular disease. The study enrolled 65 adults aged between 19 and 69 who smoked but had no clinically significant disease and were not taking regular medications, according to the research report. Participants were randomly allocated by an independent third party to receive either perilla oil capsules or visually identical placebo capsules for eight weeks.

The intervention delivered 4.8 grams of perilla oil per day, administered as three capsules twice daily. The trial was designed to determine whether this relatively simple nutritional intervention could modify measurable aspects of coagulation and inflammation.

That distinction matters. The researchers were not testing whether perilla oil could treat cardiovascular disease. They were testing whether it could influence physiological processes associated with cardiovascular risk.

What perilla oil contains

The central nutritional component is ALA. Unlike EPA and docosahexaenoic acid, or DHA, which are long-chain omega-3 fatty acids found in significant quantities in oily fish and certain marine-derived products, ALA is an essential fatty acid obtained primarily from plants.

Perilla oil is particularly notable because ALA can constitute a very large proportion of its fatty-acid profile. The exact percentage varies according to plant variety, cultivation conditions and processing, but the researchers describe perilla oil as a rich dietary source of ALA. Previous literature has reported concentrations approaching 70% in some oils.

ALA is essential because humans cannot synthesise it from scratch. It can, however, be metabolically converted into longer-chain omega-3 fatty acids. The conversion of ALA to EPA occurs, although it is limited and variable, while conversion to DHA is considerably less efficient. This biochemical distinction is important when describing perilla oil as an alternative to fish oil.

Perilla oil is a plant-based source of omega-3 fatty acid, but it is not nutritionally identical to fish oil. Fish oil provides EPA and DHA directly. Perilla oil provides predominantly ALA, from which the body can produce some EPA and much smaller amounts of DHA.

The new study is nevertheless significant because the researchers observed an increase not only in ALA but also in plasma EPA following perilla oil supplementation.

The trial found changes in platelet function

One of the most important findings concerned platelet activity.

Platelets are small blood components that respond rapidly when a blood vessel is damaged. They adhere to exposed tissue, become activated and aggregate to help form a clot. This process is essential for preventing bleeding, but excessive or inappropriate platelet activation can contribute to arterial thrombosis.

The researchers measured collagen-induced ADP closure time, commonly reported as C-ADP CT, as part of their assessment of platelet function. After eight weeks, the perilla oil group showed a statistically significant prolongation of this measurement compared with placebo, with a reported P value of 0.045.

In practical terms, the finding indicates that perilla oil supplementation altered the platelet response measured by the test, consistent with reduced platelet reactivity under the experimental conditions.

It is important not to translate this into the claim that perilla oil “thins the blood” in the clinical sense. Platelet function and coagulation are related but distinct biological systems, and a laboratory change in platelet-function testing does not automatically mean that a person has a lower incidence of thrombosis.

Nor does the result mean that people taking anticoagulant or antiplatelet medication should add perilla oil without medical advice. The study was conducted in healthy participants who were not taking regular medications, and its eight-week duration was insufficient to establish long-term safety or interactions with cardiovascular drugs.

Inflammation also changed

The second major finding involved inflammatory signalling.

The researchers measured messenger RNA expression associated with tumour necrosis factor-alpha, or TNF-α, and T-box transcription factor 21, known as TBX21. TNF-α is a well-established inflammatory mediator involved in immune regulation and numerous chronic inflammatory processes. TBX21 encodes the transcription factor T-bet, which has an important role in immune-cell differentiation and inflammatory responses.

Following eight weeks of supplementation, expression of both genes was significantly lower in the perilla oil group. TNF-α expression fell with a reported P value of 0.027, while TBX21 expression fell with a P value of 0.022.

These results provide a plausible biological connection between increased omega-3 availability and altered inflammatory signalling.

They do not, however, prove that perilla oil prevents inflammation throughout the body or prevents cardiovascular events. Gene expression is a mechanistic biomarker, not a clinical endpoint. A reduction in inflammatory gene expression can be scientifically meaningful while still requiring further research to determine whether it produces measurable improvements in disease outcomes.

That distinction is particularly important in nutrition science, where promising changes in biomarkers frequently require much larger trials before their effects on morbidity and mortality can be established.

Blood tests confirmed increased omega-3 status

The study’s biochemical findings strengthen the interpretation that participants were actually absorbing and incorporating the fatty acids supplied by the intervention.

After eight weeks, ALA concentrations increased significantly in both plasma and red blood cells. The plasma increase had a reported P value of 0.003, while the red-blood-cell increase had a P value of 0.013. Plasma EPA also increased, with a reported P value of 0.019.

This matters because it establishes that the intervention was not merely a theoretical source of omega-3. The fatty acids from perilla oil were reflected in measurable changes in participants’ lipid profiles.

The researchers also reported a positive correlation between EPA concentrations and longer C-ADP closure times. This association is consistent with the possibility that greater omega-3 availability contributed to the observed change in platelet function, although correlation alone cannot establish causation.

The findings fit within a broader body of research showing that omega-3 fatty acids can influence cell membranes, lipid mediators, platelet activity and inflammatory pathways. The biological effects of individual omega-3 fatty acids are not interchangeable, however, and ALA should not automatically be regarded as equivalent to EPA or DHA.

The high-fat, high-glucose test was more cautious

One of the study’s most useful findings is also one of its less publicised limitations.

The researchers subjected participants to a high-fat, high-glucose loading test intended to examine cardiovascular responses under metabolic stress. Perilla oil supplementation did not produce significant benefits in this test.

That result prevents an overly broad interpretation of the research. The intervention produced measurable changes in platelet and inflammatory biomarkers under the conditions studied, but it did not demonstrate an across-the-board improvement in every cardiovascular response.

The researchers suggested that a longer supplementation period might be required before effects become detectable under metabolic stress. This is a reasonable hypothesis, but it remains a hypothesis requiring further investigation rather than an established conclusion.

The study therefore provides evidence of biological activity rather than proof of clinical cardiovascular protection.

Perilla oil is not a substitute for smoking cessation

The population selected for this research also demands particular caution in interpreting the results.

Smoking remains one of the most important modifiable cardiovascular risk factors. No dietary oil can neutralise the cardiovascular consequences of tobacco exposure. Smoking damages blood vessels, promotes oxidative stress and inflammation, increases thrombogenic potential and contributes to atherosclerotic disease.

Consequently, the most clinically important intervention for a smoker remains stopping smoking.

The significance of the SeoulTech study is different. It demonstrates that even in healthy smokers exposed to substantial oxidative and inflammatory stress, a dietary source of ALA can measurably modify certain biological pathways. That makes the findings relevant to nutritional prevention research, but it does not transform perilla oil into a protective treatment for smokers.

Tatcha

Oil-Balancing Ritual

Recommended for
Combo to Oily, Oily, Clarifying, Healthy Aging, Pore Minimizing, Smoothing

Formulated without
Mineral oil, synthetic fragrances, sulfate detergents, parabens, urea, DEA, TEA, or phthalates.

Non-comedogenic, Dermatologist-tested, Cruelty-free

Order Now

A plant-based omega-3 option with important qualifications

The study could nevertheless have practical significance for people seeking plant-based sources of omega-3 fatty acids.

The American Heart Association’s current dietary guidance emphasises overall dietary patterns rather than individual “superfoods”. Its 2026 guidance recommends replacing saturated fats with healthier unsaturated fats and prioritising vegetables, fruits, whole grains, healthy protein sources and minimally processed foods.

Perilla oil fits within that broader framework as a polyunsaturated plant oil rich in ALA. Other established dietary sources of ALA include flaxseed, walnuts, soybean oil and canola oil. The nutritional objective should therefore be viewed as part of an overall dietary pattern rather than as dependence on a single supplement.

This is particularly relevant for vegans and vegetarians who do not consume fish. Perilla oil can provide ALA without animal products. Algal products can provide direct DHA and, depending on the product, EPA, making them another option for people seeking marine-type long-chain omega-3s without consuming fish.

The new study strengthens the case for considering perilla oil in cardiovascular nutrition research, but it does not overturn existing evidence regarding the differences between ALA, EPA and DHA. The American Heart Association continues to recommend dietary patterns that include healthy unsaturated fats and, for people who consume seafood, regular fish consumption.

What the study does not prove

The most important limitation is the small sample size. Sixty-five participants provide useful evidence for a controlled mechanistic trial, but they are nowhere near enough to determine whether perilla oil reduces heart attacks, strokes, cardiovascular mortality or other major clinical outcomes across a general population.

The intervention also lasted only eight weeks. Cardiovascular disease develops over years or decades, and changes in short-term biomarkers cannot automatically be extrapolated into long-term reductions in disease.

The participants were healthy smokers, meaning the results cannot necessarily be generalised to non-smokers, older adults with cardiovascular disease, people with diabetes, people taking antiplatelet drugs or anticoagulants, or populations with different dietary and genetic backgrounds.

The trial also did not demonstrate a reduction in clinical cardiovascular events. Its endpoints were laboratory and molecular measurements involving platelet function, fatty-acid composition and inflammatory gene expression.

These limitations do not diminish the quality of the findings. They define what the research has actually established.

Tatcha

THE STARTER RITUAL SET Nourishing for Normal to Dry Skin US$95 (US$140 value)

Discover the ritual for normal to dry skin. This two-week introductory set nourishes and hydrates skin for youthful radiance. Now with The Silk Peony eye cream, this set of essentials cares for your complexion deeply and fully.

What’s Included
The Camellia Cleansing Oil (Mini: 50 ml / 1.7 fl. oz.)
The Rice Polish: Classic (Mini: 15 g / 0.5 oz.)
The Essence (Mini: 25 ml / 0.8 fl. oz)
The Silk Serum (Mini: 10 ml / 0.34 fl. oz.)
The Silk Cream (Mini: 15 ml / 0.5 fl. oz.)

Order Now

Why this matters for cardiovascular nutrition

The SeoulTech trial is valuable because it moves perilla oil research from traditional dietary use and preclinical investigation into controlled human experimentation.

Earlier research has suggested potentially favourable effects from perilla seed oil, including experimental evidence involving lipid metabolism and inflammatory pathways. A 2025 animal study, for example, found that perilla seed oil altered lipid metabolism and improved several markers of diet-induced hyperlipidaemia in rats, although animal findings cannot be assumed to apply directly to humans.

The 2026 human trial supplies a different level of evidence. It shows that eight weeks of supplementation can measurably change circulating ALA and EPA while modifying platelet and inflammatory responses in humans.

The next stage should be larger randomised trials involving diverse populations, longer follow-up periods and clinically meaningful endpoints. Researchers will need to establish whether the observed changes persist, whether they translate into improved vascular function, how different doses perform, whether effects vary according to smoking status and diet, and whether long-term supplementation affects actual cardiovascular outcomes.

An old food with new scientific evidence

Perilla oil’s significance ultimately lies in the intersection between traditional food culture and contemporary clinical nutrition.

For generations, Perilla frutescens has been incorporated into East Asian diets without requiring the scientific terminology now used to describe its fatty-acid composition. Modern analytical methods can identify ALA, EPA and molecular inflammatory markers, allowing researchers to investigate biological effects that traditional food practices could not quantify.

The SeoulTech study does not establish perilla oil as a cardiovascular medicine. It establishes something more precise and scientifically defensible: eight weeks of daily perilla oil supplementation at 4.8 grams per day altered platelet function, increased circulating omega-3 fatty acids and reduced expression of selected inflammatory genes in healthy smokers.

That is a meaningful finding, particularly because it was demonstrated in a randomised, double-blind, placebo-controlled human trial. It also provides a foundation for investigating whether a culturally established, plant-derived food ingredient can contribute to cardiovascular risk reduction when incorporated into an otherwise healthy dietary pattern.

For now, the evidence supports treating perilla oil as a promising nutritional intervention rather than a proven cardiovascular therapy. Smoking cessation, blood-pressure control, appropriate cholesterol management, physical activity, healthy body weight and a high-quality dietary pattern remain central to cardiovascular prevention. The new research adds perilla oil to a growing scientific conversation about how plant-derived fats may influence the biological processes that precede cardiovascular disease.

The distinction between possibility and proof is essential. Perilla oil has now demonstrated measurable cardiovascular-related effects in humans. Whether those effects ultimately translate into fewer cardiovascular events is the question that the next generation of clinical trials must answer.

Sources: